Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
This study has been completed.
Study NCT01120210 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on May 6, 2010. Last Updated on July 8, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
JNJ-39588146 5 ng/kg/min
JNJ-39588146 15 ng/kg/min
JNJ-39588146 30 ng/kg/min
JNJ-39588146 5, 15, or 30 ng/kg/min
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers